Leila Kheirandish-Gozal1, Eduard Peris2, David Gozal3. 1. Section of Sleep Medicine, Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL, USA. Electronic address: lgozal@peds.bsd.uchicago.edu. 2. Section of Sleep Medicine, Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL, USA. 3. Section of Sleep Medicine, Department of Pediatrics, Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL, USA. Electronic address: dgozal@uchicago.edu.
Abstract
AIMS/HYPOTHESIS: Obstructive sleep apnoea (OSA) is a common health problem in children. African American (AA) and obese children have higher prevalence of OSA, and are also at a higher risk of reduced vitamin D levels. We hypothesised that OSA would be associated with lower levels of plasma 25-hydroxyvitamin D (25(OH)D) and increase in the risk of metabolic dysfunction and systemic inflammation. METHODS: In this observational cross-sectional study, 176 prospectively recruited children (mean age: 6.8±0.8 years) underwent overnight polysomnographic evaluation and a fasting blood draw the morning after the sleep study. In addition to lipid profile, homeostatic model of insulin resistance (HOMA-IR) and high-sensitivity C-reactive protein (hsCRP) assays and plasma 25(OH)D levels were assessed using ELISA kits. RESULTS: AA children, obese children and children with OSA had significantly lower 25(OH)D levels. Linear associations emerged between 25(OH)D plasma levels and body mass index (BMI) z-score, hsCRP and HOMA-IR, as well as with apnoea-hypopnoea index (AHI) and oxygen saturation (SpO2) nadir, the latter two associations remaining statistically significant even when controlling for all other potential confounders, and independently accounting for 17.7% of the variance in 25(OH)D (p<0.01). CONCLUSIONS: 25(OH)D levels are reduced in paediatric OSA, in AA children and in obese children, particularly when all are present, and may play a role in modulating the degree of insulin resistance and systemic inflammation. The short-term and long-term significance of reduced 25(OH)D in paediatric OSA remains undefined.
AIMS/HYPOTHESIS: Obstructive sleep apnoea (OSA) is a common health problem in children. African American (AA) and obesechildren have higher prevalence of OSA, and are also at a higher risk of reduced vitamin D levels. We hypothesised that OSA would be associated with lower levels of plasma 25-hydroxyvitamin D (25(OH)D) and increase in the risk of metabolic dysfunction and systemic inflammation. METHODS: In this observational cross-sectional study, 176 prospectively recruited children (mean age: 6.8±0.8 years) underwent overnight polysomnographic evaluation and a fasting blood draw the morning after the sleep study. In addition to lipid profile, homeostatic model of insulin resistance (HOMA-IR) and high-sensitivity C-reactive protein (hsCRP) assays and plasma 25(OH)D levels were assessed using ELISA kits. RESULTS: AA children, obesechildren and children with OSA had significantly lower 25(OH)D levels. Linear associations emerged between 25(OH)D plasma levels and body mass index (BMI) z-score, hsCRP and HOMA-IR, as well as with apnoea-hypopnoea index (AHI) and oxygen saturation (SpO2) nadir, the latter two associations remaining statistically significant even when controlling for all other potential confounders, and independently accounting for 17.7% of the variance in 25(OH)D (p<0.01). CONCLUSIONS: 25(OH)D levels are reduced in paediatric OSA, in AA children and in obesechildren, particularly when all are present, and may play a role in modulating the degree of insulin resistance and systemic inflammation. The short-term and long-term significance of reduced 25(OH)D in paediatric OSA remains undefined.
Authors: Antonia Barceló; Cristina Esquinas; Javier Piérola; Mónica De la Peña; Manuel Sánchez-de-la-Torre; Josep María Montserrat; José María Marín; Joaquín Duran; Meritxell Arqué; Josep Miquel Bauça; Ferrán Barbé Journal: Respiration Date: 2012-11-15 Impact factor: 3.580
Authors: M Reyman; A A Verrijn Stuart; M van Summeren; M Rakhshandehroo; R Nuboer; F K de Boer; H J van den Ham; E Kalkhoven; B Prakken; H S Schipper Journal: Int J Obes (Lond) Date: 2013-05-20 Impact factor: 5.095
Authors: Michelle Science; Jonathon L Maguire; Margaret L Russell; Marek Smieja; Stephen D Walter; Mark Loeb Journal: Clin Infect Dis Date: 2013-05-15 Impact factor: 9.079
Authors: H Eimar; H Saltaji; S Ghorashi; D Isfeld; J E MacLean; D Gozal; D Graf; C Flores-Mir Journal: Osteoporos Int Date: 2017-01-18 Impact factor: 4.507
Authors: Umesh Goswami; Kristine E Ensrud; Misti L Paudel; Susan Redline; Eva S Schernhammer; James M Shikany; Katie L Stone; Ken M Kunisaki Journal: Ann Am Thorac Soc Date: 2016-05
Authors: Lisa B Matlen; Daniel G Whitney; Daniel Whibley; Erica C Jansen; Ronald D Chervin; Galit Levi Dunietz Journal: J Clin Sleep Med Date: 2021-09-01 Impact factor: 4.324